The University of Nebraska Medical Center Pulmonary Research Lab is seeking smoking and non-smoking adults interested in participating in studies that will test the effectiveness of drugs used to treat lung disease.
Participants may enroll in only one study at a time. Each study requires participants to make up to 10 visits and can last up to 16 weeks. Those completing the study will receive a stipend ranging from $250 to $400. Participants will receive a physical exam, breathing tests, blood tests, an electrocardiogram and chest X-ray.
One study seeks eight adults between the ages of 19 to 75 who are coughing up mucus on a daily basis. This study will test the effectiveness of the pill form of Mucomyst, which is currently used to treat lung disorders.
Another study seeks adults age 45 and older who are diagnosed with asthma, bronchitis, emphysema or chronic obstructive pulmonary disease. It will compare the effectiveness of Serevent to Theophylline. Both drugs open the airways allowing patients to breathe easier.
For more information, call Jim Melson, (402) 559-9928. UNMC is the only public academic health science center in the state.
Through its commitment to research, education and patient care, UNMC has established itself as one of the country’s leading centers for and cancer research and treatment and solid organ transplantation. Nearly $25 million in research grants and contracts are awarded to UNMC scientists annually. In addition, UNMC’s educational programs are responsible for training more health professionals practicing in Nebraska than any other institution.